These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38504997)

  • 21. Impact of antibiotics on gut microbiome composition and resistome in the first years of life in low- to middle-income countries: A systematic review.
    Luchen CC; Chibuye M; Spijker R; Simuyandi M; Chisenga C; Bosomprah S; Chilengi R; Schultsz C; Mende DR; Harris VC
    PLoS Med; 2023 Jun; 20(6):e1004235. PubMed ID: 37368871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries.
    Lim C; Ashley EA; Hamers RL; Turner P; Kesteman T; Akech S; Corso A; Mayxay M; Okeke IN; Limmathurotsakul D; van Doorn HR
    Clin Microbiol Infect; 2021 Oct; 27(10):1391-1399. PubMed ID: 34111583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a cross-sectoral antimicrobial resistance capability assessment framework.
    Ferdinand AS; McEwan C; Lin C; Betham K; Kandan K; Tamolsaian G; Pugeva B; McKenzie J; Browning G; Gilkerson J; Coppo M; James R; Peel T; Levy S; Townell N; Jenney A; Stewardson A; Cameron D; Macintyre A; Buising K; Howden BP
    BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38232993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship?
    Walia K; Mendelson M; Kang G; Venkatasubramanian R; Sinha R; Vijay S; Veeraraghavan B; Basnyat B; Rodrigues C; Bansal N; Ray P; Mathur P; Gopalakrishnan R; Ohri VC
    Lancet Infect Dis; 2023 Aug; 23(8):e301-e309. PubMed ID: 37290476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Dooley L; Ferroni E; Al-Ansary LA; van Driel ML; Bawazeer GA; Jones MA; Hoffmann TC; Clark J; Beller EM; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD006207. PubMed ID: 36715243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AMR Surveillance in low and middle-income settings - A roadmap for participation in the Global Antimicrobial Surveillance System (GLASS).
    Seale AC; Gordon NC; Islam J; Peacock SJ; Scott JAG
    Wellcome Open Res; 2017; 2():92. PubMed ID: 29062918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Closing the GAP in Antimicrobial Resistance Policy in Benin and Burkina Faso.
    Sariola S; Butcher A; Cañada JA; Aïkpé M; Compaore A
    mSystems; 2022 Aug; 7(4):e0015022. PubMed ID: 35894597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of publication to TBI burden ratio of low- and middle-income countries versus high-income countries: how can we improve worldwide care of TBI?
    Tropeano MP; Spaggiari R; Ileyassoff H; Park KB; Kolias AG; Hutchinson PJ; Servadei F
    Neurosurg Focus; 2019 Nov; 47(5):E5. PubMed ID: 31675715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A parallel and silent emerging pandemic: Antimicrobial resistance (AMR) amid COVID-19 pandemic.
    Rehman S
    J Infect Public Health; 2023 Apr; 16(4):611-617. PubMed ID: 36857834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 'LMICs as reservoirs of AMR': a comparative analysis of policy discourse on antimicrobial resistance with reference to Pakistan.
    Khan MS; Durrance-Bagale A; Legido-Quigley H; Mateus A; Hasan R; Spencer J; Hanefeld J
    Health Policy Plan; 2019 Apr; 34(3):178-187. PubMed ID: 30977804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Revisiting the blind spot of substandard and fake drugs as drivers of antimicrobial resistance in LMICs.
    Gulumbe BH; Adesola RO
    Ann Med Surg (Lond); 2023 Feb; 85(2):122-123. PubMed ID: 36845783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attention to the Tripartite's one health measures in national action plans on antimicrobial resistance.
    Munkholm L; Rubin O; Bækkeskov E; Humboldt-Dachroeden S
    J Public Health Policy; 2021 Jun; 42(2):236-248. PubMed ID: 33597731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flare of the silent pandemic in the era of the COVID-19 pandemic: Obstacles and opportunities.
    Rayan RA
    World J Clin Cases; 2023 Feb; 11(6):1267-1274. PubMed ID: 36926133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The level of countries' preparedness to health risks during Covid-19 and pre-pandemic: the differential response to health systems building blocks and socioeconomic indicators.
    Da'ar OB; Kalmey F
    Health Econ Rev; 2023 Mar; 13(1):16. PubMed ID: 36917372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Filling the gaps in the global prevalence map of clinical antimicrobial resistance.
    Oldenkamp R; Schultsz C; Mancini E; Cappuccio A
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33372157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drivers of inappropriate antibiotic use in low- and middle-income countries.
    Otaigbe II; Elikwu CJ
    JAC Antimicrob Resist; 2023 Jun; 5(3):dlad062. PubMed ID: 37265987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial Resistance as a Hidden Menace Lurking Behind the COVID-19 Outbreak: The Global Impacts of Too Much Hygiene on AMR.
    Rezasoltani S; Yadegar A; Hatami B; Asadzadeh Aghdaei H; Zali MR
    Front Microbiol; 2020; 11():590683. PubMed ID: 33384670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial Resistance in New Zealand-A One Health Perspective.
    Pattis I; Weaver L; Burgess S; Ussher JE; Dyet K
    Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740184
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.